Sickle Cell Texas Marc Thomas Foundation (EIN 742934173) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

Linda T Wade

Phone

5124589767

Tax Period

2023-01-01 to 2023-12-31

Sickle Cell Texas Marc Thomas Foundation, founded in 1999, is a small nonprofit in the Health Care sector that reported $721K in total revenue in fiscal year 2023. Revenue decreased 5% compared to the prior year. Expenses of $667K left a modest 7% surplus.

Mission

Sickle Cell Association of Texas Marc Thomas Foundations mission is to enhance and improve the quality of life for those living with sickle cell disease and trait, providing hope, help, and support.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $711,921

Program Service Revenue $7,167

Investment Income $1,523

Other Revenue $0

TOTAL REVENUE $720,611

Expense Breakdown

Grants Paid $63,834

Salaries & Benefits $431,142

Fundraising Expenses $0

Program Expenses $591,412

Other Expenses $171,954

TOTAL EXPENSES $666,930

Year-over-Year Comparison

	2023	2022	Change
Revenue	$720,611	$759,512	-0.1%
Expenses	$666,930	$670,906	0.0%
Net Income	$53,681	$88,606	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$222,512

Total Directors

$100,320

Key Employees

$122,192

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Alysian Thomas	Chief Operating Officer	040.00	Officer Key Emp	$122,192	$0	$122,192
Linda T Wade	President	040.00	Officer Director	$100,320	$0	$100,320
Sharon Newcomb-Kase	Director	001.00	Director	$0	$0	$0
Melissa Frei-Jones MD	Director	001.00	Director	$0	$0	$0
Alfretta Hicks	Director	001.00	Director	$0	$0	$0
Carlyle Small	Director	001.00	Director	$0	$0	$0
Ayanna Edmonson	Director	003.00	Director	$0	$0	$0
Robert Kingham	Board Chair	001.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$720,611	$666,930	$506,159	$53,681
2022	$759,512	$670,906	$459,730	$88,606
2021	$710,113	$752,242	$363,696	$-42,129
2020	$988,894	$730,309	$404,988	$258,585
2019	$750,036	$696,786	$146,403	$53,250
2018	$743,599	$675,791	$94,007	$67,808

Sickle Cell Texas Marc Thomas Foundation